Featured Research

from universities, journals, and other organizations

Alcohol Researchers Show "Friendly" Virus Slows HIV Cell Growth

Date:
September 6, 2001
Source:
NIH/National Institute On Alcohol Abuse And Alcoholism
Summary:
A team of alcohol researchers led by Jack Stapleton, M.D., of the Department of Internal Medicine, University of Iowa College of Medicine and the Iowa City Veterans Affairs Medical Center, report in the September 6 New England Journal of Medicine, Volume 345, 2001 (Effect of co-infection with GB virus type C (Hepatitis G Virus) on survival of HIV-infected individuals: In vitro co-infection suggests inhibition of HIV replication by GB virus C) that GB virus type C (GBV-C) appears to have retarded the progression of human immunodeficiency virus in a 12-year clinical study of HIV patients.

A team of alcohol researchers led by Jack Stapleton, M.D., of the Department of Internal Medicine, University of Iowa College of Medicine and the Iowa City Veterans Affairs Medical Center, report in the September 6 New England Journal of Medicine, Volume 345, 2001 (Effect of co-infection with GB virus type C (Hepatitis G Virus) on survival of HIV-infected individuals: In vitro co-infection suggests inhibition of HIV replication by GB virus C) that GB virus type C (GBV-C) appears to have retarded the progression of human immunodeficiency virus in a 12-year clinical study of HIV patients. Using an infectious molecular clone of GBV-C, the same team showed in a laboratory study that GBV-C reduces the growth rate of HIV in cultured human T-cells, a form of white blood cells or lymphocytes.

The clinical finding came while Dr. Stapleton and his colleagues explored relationships among alcohol, seronegative hepatitis C virus (HCV) infection, GBV-C infection, and liver disease in patients of the University of Iowa HIV/AIDS Clinic. Damaging effects of alcohol on immune function, including effects in patients with HIV and AIDS, are a longstanding focus of alcohol research.

In the study population of 362 HIV-infected patients, 144 (39.7 percent) were co-infected with GBV-C, a proportion similar to that of GBV-C co-infection among all HIV patients. Originally known as hepatitis G, GBV-C also infects about 15 percent of patients with hepatitis C. Unlike hepatitis C, however, GBV-C causes neither hepatitis nor any other clinical symptoms.

"From several earlier studies that examined the relationship of HIV and GBV-C, we suspected that GBV-C might exert a positive effect toward slowing the progress of HIV infection. We expanded the previous research by looking at a very large group of patients followed at our clinic between 1988 and 2000 and found that HIV-infected people without GBV-C infection were 3.68 times more likely to die than those with GBV-C," Dr. Stapleton said. "This leads us to believe that GBV-C is one factor explaining how some people live longer and more healthily with their HIV infection than other HIV-infected people do."

The laboratory component of the study used an infectious molecular clone of GBV-C and HIV culture systems developed by Jinhua Xiang, M.D., and Sabina Wũnschmann, Ph.D., in Dr. Stapleton's University of Iowa laboratory and at the Iowa City Veterans Affairs Medical Center to demonstrate that, like HIV, GBV-C grows in CD-4 positive "helper" T-cells. In a series of experiments to determine if GBV-C altered HIV replication in vitro, the researchers tested the production of p24 antigen, a marker of HIV growth, in cell cultures infected with HIV alone, GBV-C alone, and both HIV and HGV-C. They found that cells infected with both viruses produced 30 to 40 percent less HIV than those infected with HIV only.

"We are now working to understand precisely how GBV-C inhibits HIV from growing," Dr. Stapleton said. "We do not know whether GBV directly interferes with HIV, or if the GBV stimulates cellular proteins, such as interferon or immune cytokines, that protect the cells against HIV growth."

Understanding the mechanism by which GBV-C retards HIV progression holds promise for designing new treatments that will prolong life for HIV-infected patients. "It may be reasonable to consider using GBV-C as a novel therapeutic vector to delay disease progression," Dr. Stapleton said.

"Alcohol is toxic to every organ system. Hence, alcohol research spans the spectrum of biomedical research," said NIAAA Director Enoch Gordis, M.D. "It is gratifying when the work of alcohol researchers sheds light on diseases other than alcoholism-especially diseases with consequences to individuals and society such as those of HIV-AIDS, the most far-reaching epidemic of our time."

The National Institute on Alcohol Abuse and Alcoholism, a component of the National Institutes of Health, U.S. Department of Health and Human Services, conducts and supports approximately 90 percent of U.S. research on the causes, consequences, prevention, and treatment of alcohol abuse, alcoholism, and alcohol problems and disseminates research findings to science, practitioner, policy making, and general audiences.


Story Source:

The above story is based on materials provided by NIH/National Institute On Alcohol Abuse And Alcoholism. Note: Materials may be edited for content and length.


Cite This Page:

NIH/National Institute On Alcohol Abuse And Alcoholism. "Alcohol Researchers Show "Friendly" Virus Slows HIV Cell Growth." ScienceDaily. ScienceDaily, 6 September 2001. <www.sciencedaily.com/releases/2001/09/010906072556.htm>.
NIH/National Institute On Alcohol Abuse And Alcoholism. (2001, September 6). Alcohol Researchers Show "Friendly" Virus Slows HIV Cell Growth. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2001/09/010906072556.htm
NIH/National Institute On Alcohol Abuse And Alcoholism. "Alcohol Researchers Show "Friendly" Virus Slows HIV Cell Growth." ScienceDaily. www.sciencedaily.com/releases/2001/09/010906072556.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins